Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia-Reference-Cited by-同舟云学术

Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia

Published:2020-06 Issue:6 Volume:28 Page:662-668
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Al-Omar Hussain Abdulrahman,Attuwaijri Abdulaziz Abdulhadi,Aljuffali Ibrahim Abdulrahman

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference42 articles.

1. The workshop as a qualitative research approach: Lessons learnt from a “critical thinking through writing” workshop;Ahmed;Turk. Online J. Design Art Commun.,2018

2. Variation in health technology assessment and reimbursement processes in Europe;Akehurst;Value Health,2017

3. What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: Workshop conclusions;Al-Omar;Expert Rev. Pharmacoecon. Outcomes Res.,2020

4. Health technology assessment of medicines in Greece: Pharmaceutical industry executives' views;Armataki;Int. J. Technol. Assess. Health Care,2014

5. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review;Babar;Res. Social Adm. Pharm.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing a Roadmap for Health Technology Assessment Implementation in Algeria;Cureus;2024-07-28

2. Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia;Journal of Medical Economics;2024-03-11

3. Understanding consumers’ adoption of e-pharmacy in Qatar: applying the unified theory of acceptance and use of technology;Journal of Science and Technology Policy Management;2024-01-24

4. Implementation of risk-sharing agreements in Saudi Arabia: Comparison and reflection on the NICE Model;Tropical Journal of Pharmaceutical Research;2023-06-07

5. Budget impact analysis of a bioprosthetic valve with a novel tissue versus mechanical aortic valve replacement in patients older than 65 years with aortic stenosis in Saudi Arabia;Journal of Medical Economics;2022-10-20